BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38783670)

  • 1. [Cardiac amyloidosis : simplifying the diagnosis of a complex disease].
    Dayer N; Monney P; Hugelshofer S
    Rev Med Suisse; 2024 May; 20(875):1010-1017. PubMed ID: 38783670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
    Rubin J; Maurer MS
    Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac amyloidosis: updates in diagnosis and management.
    Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
    Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding and recognizing cardiac amyloidosis.
    McVeigh T; Tennyson C
    JAAPA; 2020 Oct; 33(10):16-20. PubMed ID: 32941304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transthyretin cardiac amyloidosis: A treatable form of heart failure with a preserved ejection fraction.
    Griffin JM; Maurer MS
    Trends Cardiovasc Med; 2021 Jan; 31(1):59-66. PubMed ID: 31889610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [What should we know about cardiac amyloidosis? From clinical signs to treatment].
    Földeák D; Nemes A; Kalapos A; Domsik P; Kormányos Á; Krenács L; Bagdi E; Borbényi Z
    Orv Hetil; 2017 Nov; 158(46):1811-1818. PubMed ID: 29135289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ten questions about transthyretin amyloidosis].
    Giovannetti A; Accietto A; Massa P; Leone O; Guaraldi P; Saturi G; Caponetti AG; Sguazzotti M; Ponziani A; Gagliardi C; Galiè N; Cortelli P; Longhi S; Biagini E
    G Ital Cardiol (Rome); 2022 Sep; 23(9):676-685. PubMed ID: 36039718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress and challenges in the treatment of cardiac amyloidosis: a review of the literature.
    Adam RD; Coriu D; Jercan A; Bădeliţă S; Popescu BA; Damy T; Jurcuţ R
    ESC Heart Fail; 2021 Aug; 8(4):2380-2396. PubMed ID: 34089308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid transthyretin cardiac amyloidosis with different manifestations, test findings and types.
    Budweg J; Al-Ani M; Assaf Y; Parker A; Aranda J
    BMJ Case Rep; 2023 Apr; 16(4):. PubMed ID: 37080632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac amyloidosis: an update on diagnosis, current therapy, and future directions.
    Khedraki R
    Curr Opin Cardiol; 2022 May; 37(3):272-284. PubMed ID: 35612939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Suspected cardiac amyloidosis - diagnostic steps for evaluation].
    Feldmann K; Hamm CW; Aßmus B
    Dtsch Med Wochenschr; 2020 Aug; 145(16):1162-1168. PubMed ID: 32791553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the diagnosis and management of cardiac amyloidosis.
    Sher T; Gertz MA
    Future Cardiol; 2014 Jan; 10(1):131-46. PubMed ID: 24344669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transthyretin amyloid cardiomyopathy.
    Garcia-Pavia P; Domínguez F; Gonzalez-Lopez E
    Med Clin (Barc); 2021 Feb; 156(3):126-134. PubMed ID: 33138983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the diagnosis and treatment of transthyretin amyloid cardiomyopathy.
    Vaishnav J; Brown E; Sharma K
    Prog Cardiovasc Dis; 2024; 82():113-124. PubMed ID: 38246305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early diagnosis and management of cardiac amyloidosis: A clinical perspective.
    Bellofatto IA; Schindler TH; Portincasa P; Carbone F; Canepa M; Liberale L; Montecucco F
    Eur J Clin Invest; 2024 Jun; 54(6):e14160. PubMed ID: 38217112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiac amyloidosis and aortic stenosis: what do we know?].
    Sena G; Ruotolo I; Zaccaro A; Ponziani A; Saturi G; Gagliardi C; Biagini E; Longhi S
    G Ital Cardiol (Rome); 2024 Jul; 25(7):483-490. PubMed ID: 38916463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute cardiac failure secondary to senile systemic amyloidosis.
    Bodard Q; Roca F; Dilly B; Laurent D; Chassagne P
    Age Ageing; 2016 Nov; 45(6):908-909. PubMed ID: 27103598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subtype-Specific Interactions and Prognosis in Cardiac Amyloidosis.
    Sperry BW; Vranian MN; Hachamovitch R; Joshi H; Ikram A; Phelan D; Hanna M
    J Am Heart Assoc; 2016 Mar; 5(3):e002877. PubMed ID: 27013539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis.
    Gertz MA; Benson MD; Dyck PJ; Grogan M; Coelho T; Cruz M; Berk JL; Plante-Bordeneuve V; Schmidt HHJ; Merlini G
    J Am Coll Cardiol; 2015 Dec; 66(21):2451-2466. PubMed ID: 26610878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misconceptions and Facts About Cardiac Amyloidosis.
    Nguyen FD; Rodriguez M; Krittanawong C; Witteles R; Lenihan DJ
    Am J Cardiol; 2021 Dec; 160():99-105. PubMed ID: 34610875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.